REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 151 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,101,635 | -52.0% | 201,566 | -47.1% | 0.06% | -49.2% |
| Q3 2021 | $10,623,000 | +73.1% | 381,302 | +84.2% | 0.13% | +55.6% |
| Q2 2021 | $6,136,000 | +4.3% | 207,008 | -1.6% | 0.08% | -6.9% |
| Q1 2021 | $5,881,000 | -8.4% | 210,403 | -7.1% | 0.09% | -16.3% |
| Q4 2020 | $6,418,000 | -56.2% | 226,465 | -61.2% | 0.10% | -65.4% |
| Q3 2020 | $14,666,000 | -19.9% | 583,363 | -22.2% | 0.30% | -32.4% |
| Q2 2020 | $18,301,000 | +66.9% | 749,430 | +1.2% | 0.44% | +21.6% |
| Q1 2020 | $10,964,000 | +2.2% | 740,778 | +4.9% | 0.37% | +28.4% |
| Q4 2019 | $10,727,000 | +424.3% | 706,013 | +502.6% | 0.28% | +331.8% |
| Q1 2016 | $2,046,000 | -23.3% | 117,168 | +50.1% | 0.07% | -26.7% |
| Q4 2015 | $2,667,000 | +85.7% | 78,078 | +5.1% | 0.09% | +63.6% |
| Q3 2014 | $1,436,000 | -84.2% | 74,289 | -72.2% | 0.06% | -81.4% |
| Q2 2014 | $9,080,000 | +7.4% | 267,054 | -0.5% | 0.30% | +10.9% |
| Q1 2014 | $8,458,000 | – | 268,518 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |